Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25 TTM Selling/general/admin expenses 42.91 M45.29 M50.64 M48.41 M 187.25 M Research & development ———— — Operating income -59.03 M-722.75 M-221.25 M-20.34 M -1.02 B Non-Operating Income, Total 38.68 M46.92 M26.6 M19.99 M 132.2 M Interest expense, net of interest capitalized 4.53 M4.42 M5.12 M4.42 M 18.5 M Non-Operating Income, excl. Interest Expenses 33.53 M44.95 M27.92 M25.11 M 131.5 M Unusual income/expense 5.15 M1.98 M-1.31 M-5.12 M 697 K Pretax income -20.35 M-675.83 M-194.65 M-344 K -891.17 M Equity in earnings 10.51 M-1.21 M9.83 M21.69 M 40.82 M Taxes -8.34 M-100.34 M-32.21 M-7 M -147.89 M Non-controlling/minority interest 20.96 M39.66 M18.56 M-13.19 M 65.99 M After tax other income/expense ———-103 K — Net income before discontinued operations -38.42 M-366.14 M-123.45 M-7.79 M -535.81 M Discontinued operations ———— — Net income -38.42 M-366.14 M-123.45 M-7.79 M -535.81 M Dilution adjustment ———— — Preferred dividends ———— — Diluted net income available to common stockholders -38.42 M-366.14 M-123.45 M-7.79 M -535.81 M Basic earnings per share (Basic EPS) -0.49-4.66-1.55-0.08 -6.78 Diluted earnings per share (Diluted EPS) -0.49-4.66-1.55-0.08 -6.78 Average basic shares outstanding 77.85 M78.56 M79.47 M79.04 M — Diluted shares outstanding 77.85 M78.56 M79.47 M79.04 M — EBITDA -47.6 M-711.29 M-209.84 M-8.9 M -977.64 M EBIT -59.03 M-722.75 M-221.25 M-20.34 M -1.02 B Cost of revenue ———— — Other cost of goods sold ———— — Depreciation & amortization (cash flow) 11.42 M11.46 M11.41 M11.44 M 45.73 M